Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 ( NPM1 ) mutation or Fms‐like tyrosine kinase 3 internal tandem duplication ( FLT3‐ ITD)-Reference-Cited by-同舟云学术

Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 ( NPM1 ) mutation or Fms‐like tyrosine kinase 3 internal tandem duplication ( FLT3‐ ITD)

Published:2020-02-26 Issue:2 Volume:190 Page:274-283
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Zhou Ya‐Lan¹,Wu Li‐Xin¹,Peter Gale Robert²,Wang Zi‐Long¹,Li Jin‐Lan¹,Jiang Hao¹,Jiang Qian¹^ORCID,Jiang Bin¹,Cao Shan‐Bo³,Lou Feng³,Sun Ying³,Wang Cheng‐Cheng³,Liu Yan‐Rong¹,Wang Yu¹,Chang Ying‐Jun¹,Xu Lan‐Ping¹^ORCID,Zhang Xiao‐Hui¹,Liu Kai‐Yan¹^ORCID,Ruan Guo‐Rui¹^ORCID,Huang Xiao‐Jun¹⁴⁵

Affiliation:

1. Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation National Clinical Research Center for Hematologic Disease Peking University Institute of Hematology Peking University People’s Hospital Beijing China

2. Department of Immunology and Inflammation Imperial College Haematology Research Center London UK

3. AcornMed Biotechnology Co., Ltd. Beijing China

4. Peking‐Tsinghua Center for Life Sciences Beijing China

5. Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies Chinese Academy of Medical Sciences Beijing China

Funder

National Natural Science Foundation of China

Beijing Municipal Science and Technology Commission

Publisher

Wiley

Subject

Hematology

Link